Applications of Gene Therapy in Cardiomyopathies (TBD)
Presenter:
We Recommend
Disclosures
Within the last 24 months, I have had financial relationship(s) with the ineligible company or companies listed below:
- Chief science officer - Lexeo Therapeutics
- Consultant Fee/Honoraria/Speaker's Bureau - Abiomed; AstraZenca; Kiniska; Cytokinetics
- Grant Support/Research Contract - Medtronic
- Equity/Stock(s)/Options - Rocket Pharmaceuticals